FDA Inspection 1181097 — Raptim Research Pvt. Ltd.
The FDA completed an inspection of Raptim Research Pvt. Ltd. on September 14, 2022 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE